Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHRISTOPHER H KWOH

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1962427534
CMS profile
43085
Location
HOUSTON, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$79,519.57

142 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Page 3 of 3; records 101–142 of 142 matching records. This page contains 42 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CHRISTOPHER H KWOH

NPI 1962427534 · CMS profile ID 43085

Allopathic & Osteopathic Physicians / Internal Medicine / Nephrology

HOUSTON, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–142 of 142 matching records. This page contains 42 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1962427534?year=2021&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CHRISTOPHER H KWOH, NPI 1962427534, CMS profile ID 43085. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–142 of 142 matching records. This page contains 42 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1962427534?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). CHRISTOPHER H KWOH, NPI 1962427534, CMS profile ID 43085. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–142 of 142 matching records. This page contains 42 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1962427534?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
CHRISTOPHER H KWOH, NPI 1962427534, CMS profile ID 43085, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–142 of 142 matching records. This page contains 42 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1962427534?year=2021&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

142 matching records · $79,519.57 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 142 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–142 of 142.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Otsuka America Pharmaceutical, Inc. $1,620.0005/19/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834745813 CMS
Otsuka America Pharmaceutical, Inc. $1,620.0005/19/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834745815 CMS
Shionogi Inc $11.6605/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851016937 CMS
Otsuka America Pharmaceutical, Inc. $1,620.0005/12/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834745809 CMS
OPKO Pharmaceuticals, LLC $13.6105/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827745723 CMS
AstraZeneca Pharmaceuticals LP $20.0305/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829518611 CMS
GlaxoSmithKline, LLC. $19.2905/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802578339 CMS
Otsuka America Pharmaceutical, Inc. $1,620.0005/05/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834745807 CMS
AstraZeneca Pharmaceuticals LP $20.0204/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829375299 CMS
GlaxoSmithKline, LLC. $20.0704/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802672197 CMS
AKEBIA THERAPEUTICS INC $19.8104/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 855447199 CMS
Otsuka America Pharmaceutical, Inc. $1,620.0004/21/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834745805 CMS
Otsuka America Pharmaceutical, Inc. $24.2404/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834745803 CMS
Otsuka America Pharmaceutical, Inc. $1,620.0004/16/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834745801 CMS
AstraZeneca Pharmaceuticals LP $16.6204/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829492909 CMS
AstraZeneca Pharmaceuticals LP $7.1004/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829632849 CMS
Otsuka America Pharmaceutical, Inc. $274.0004/14/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834745799 CMS
OPKO Pharmaceuticals, LLC $19.8404/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827745721 CMS
Otsuka America Pharmaceutical, Inc. $486.0004/09/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834745797 CMS
OPKO Pharmaceuticals, LLC $13.7504/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827745719 CMS
AstraZeneca Pharmaceuticals LP $20.6304/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829802089 CMS
GlaxoSmithKline, LLC. $19.9903/31/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802891609 CMS
Mallinckrodt Hospital Products Inc. $26.7703/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845365017 CMS
Novartis Pharmaceuticals Corporation $7.5003/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812762265 CMS
AstraZeneca Pharmaceuticals LP $22.4603/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829605517 CMS
OPKO Pharmaceuticals, LLC $11.1203/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827745717 CMS
Otsuka America Pharmaceutical, Inc. $1,620.0003/12/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834745795 CMS
Otsuka America Pharmaceutical, Inc. $1,620.0003/10/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834745793 CMS
Vifor Pharma, Inc. $23.5603/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 816095007 CMS
Novartis Pharmaceuticals Corporation $19.5403/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812762267 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.2503/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 860924997 CMS
GlaxoSmithKline, LLC. $19.6703/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802046581 CMS
Otsuka America Pharmaceutical, Inc. $486.0003/03/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834745791 CMS
AstraZeneca Pharmaceuticals LP $19.9903/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829677023 CMS
Otsuka America Pharmaceutical, Inc. $3.2902/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834745789 CMS
Otsuka America Pharmaceutical, Inc. $20.7702/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834745787 CMS
AstraZeneca Pharmaceuticals LP $20.7602/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830083087 CMS
NxStage Medical, Inc. $1,050.0002/04/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 764792082 CMS
AstraZeneca Pharmaceuticals LP $26.8502/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829370447 CMS
Mallinckrodt Hospital Products Inc. $25.1101/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845365015 CMS
OPKO Pharmaceuticals, LLC $13.8601/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827745715 CMS
Otsuka America Pharmaceutical, Inc. $717.5001/14/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834745785 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $6,258.45 142
PY2020 $11,010.68 85
PY2021 $79,519.57 142
PY2022 $87,401.00 183
PY2023 $66,596.29 149
PY2024 $142,869.67 252
PY2025 $72,917.02 202

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $114,243.97 13
PY2024 Principal investigator $133,812.05 14
PY2023 Principal investigator $137,430.92 7
PY2022 Principal investigator $39,495.46 5
PY2021 Principal investigator $8,919.98 1
PY2020 Principal investigator $16,538.00 3
PY2019 Recipient $1,208.07 13
PY2019 Principal investigator $4,524.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

13 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 CSL Behring $9,856.00 12/29/2025 Non-covered Recipient Entity
Clinical Research Strategies, Inc.
A Phase 2b/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Combined Dose-Finding and Cardiovascular Outcome Study to Investigate the Efficacy and Safety of CSL300 (Clazakizumab) in Subjects With End Stage Kidney Disease Undergoing Dialysis No dispute reported 06/30/2026 1252666569
Principal investigator 1 CSL Behring $7,392.00 11/17/2025 Non-covered Recipient Entity
Clinical Research Strategies, Inc.
A Phase 2b/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Combined Dose-Finding and Cardiovascular Outcome Study to Investigate the Efficacy and Safety of CSL300 (Clazakizumab) in Subjects With End Stage Kidney Disease Undergoing Dialysis No dispute reported 06/30/2026 1252666563
Principal investigator 1 CSL Behring $25,093.00 10/29/2025 Non-covered Recipient Entity
Clinical Research Strategies, Inc.
A Phase 2b/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Combined Dose-Finding and Cardiovascular Outcome Study to Investigate the Efficacy and Safety of CSL300 (Clazakizumab) in Subjects With End Stage Kidney Disease Undergoing Dialysis No dispute reported 06/30/2026 1252666557
Principal investigator 1 CSL Behring $56,015.10 10/17/2025 Non-covered Recipient Entity
Clinical Research Strategies, Inc.
A Phase 2b/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Combined Dose-Finding and Cardiovascular Outcome Study to Investigate the Efficacy and Safety of CSL300 (Clazakizumab) in Subjects With End Stage Kidney Disease Undergoing Dialysis No dispute reported 06/30/2026 1252666555
Principal investigator 1 CSL Behring $16.71 08/06/2025 Non-covered Recipient Entity
Clinical Research Strategies, Inc.
A Phase 2b/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Combined Dose-Finding and Cardiovascular Outcome Study to Investigate the Efficacy and Safety of CSL300 (Clazakizumab) in Subjects With End Stage Kidney Disease Undergoing Dialysis No dispute reported 06/30/2026 1252666825
Principal investigator 1 CSL Behring $603.80 07/30/2025 Non-covered Recipient Entity
Clinical Research Strategies, Inc.
A Phase 2b/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Combined Dose-Finding and Cardiovascular Outcome Study to Investigate the Efficacy and Safety of CSL300 (Clazakizumab) in Subjects With End Stage Kidney Disease Undergoing Dialysis No dispute reported 06/30/2026 1252666823
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $9,180.00 06/19/2025 Non-covered Recipient Entity
Clinical Research Strategies, Llc
BAY 948862, Clinical characteristics, treatment patterns and outcomes of patients treated with Finerenone in routine clinical practice A prospective non-interventional study. No dispute reported 06/30/2026 1225411596
Principal investigator 1 VERTEX PHARMACEUTICALS INCORPORATED $3,549.00 05/16/2025 Non-covered Recipient Entity
CLINICAL RESEARCH STRATEGIES INC. ROMANO NORTH MAIN OFFICE
A Study of the Prevalance of Apolipoprotein L1 (APOL1) Alleles Among Individuals With Proteinuric Kidney Disease Who Are of Recent African Ancestry or Geographic Origin No dispute reported 06/30/2026 1214123360
Principal investigator 1 CSL Behring $514.52 04/22/2025 Non-covered Recipient Entity
Clinical Research Strategies, Inc.
A Phase 2b/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Combined Dose-Finding and Cardiovascular Outcome Study to Investigate the Efficacy and Safety of CSL300 (Clazakizumab) in Subjects With End Stage Kidney Disease Undergoing Dialysis No dispute reported 06/30/2026 1252666807
Principal investigator 1 CSL Behring $16.71 04/09/2025 Non-covered Recipient Entity
Clinical Research Strategies, Inc.
A Phase 2b/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Combined Dose-Finding and Cardiovascular Outcome Study to Investigate the Efficacy and Safety of CSL300 (Clazakizumab) in Subjects With End Stage Kidney Disease Undergoing Dialysis No dispute reported 06/30/2026 1252666795
Principal investigator 1 CSL Behring $484.30 03/31/2025 Non-covered Recipient Entity
Clinical Research Strategies, Inc.
A Phase 2b/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Combined Dose-Finding and Cardiovascular Outcome Study to Investigate the Efficacy and Safety of CSL300 (Clazakizumab) in Subjects With End Stage Kidney Disease Undergoing Dialysis No dispute reported 06/30/2026 1252666597
Principal investigator 1 CSL Behring $918.05 02/26/2025 Non-covered Recipient Entity
Clinical Research Strategies, Inc.
A Phase 2b/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Combined Dose-Finding and Cardiovascular Outcome Study to Investigate the Efficacy and Safety of CSL300 (Clazakizumab) in Subjects With End Stage Kidney Disease Undergoing Dialysis No dispute reported 06/30/2026 1252666583
Principal investigator 1 CSL Behring $604.78 02/25/2025 Non-covered Recipient Entity
Clinical Research Strategies, Inc.
A Phase 2b/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Combined Dose-Finding and Cardiovascular Outcome Study to Investigate the Efficacy and Safety of CSL300 (Clazakizumab) in Subjects With End Stage Kidney Disease Undergoing Dialysis No dispute reported 06/30/2026 1252666581